Search research articles
Contact Us
Filters
Showing results (1-10 of 55) with videos related to
Page
of 6
Sort By:
Expert Opinion on Investigational Drugs
|
September 24, 2008
PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home
Andrew N Billin
Skeletal Muscle
|
February 2, 2013
Satellite cell therapy - from mice to men
Akshay Bareja, Andrew N Billin
Methods in Molecular Biology (Clifton, N.J.)
|
May 9, 2018
Isolation of Skeletal Muscle Stem Cells for Phenotypic Screens for Modulators of Proliferation
Aaron C Hinken, Andrew N Billin
Current Opinion in Investigational Drugs (London, England : 2000)
|
May 10, 2008
PPARbeta/delta ligands as modulators of the inflammatory response
Kenneth S Kilgore, Andrew N Billin
Biochimica Et Biophysica Acta
|
July 3, 2007
The next generation of PPAR drugs: do we have the tools to find them?
Barry G Shearer, Andrew N Billin
Journal of Molecular Histology
|
February 4, 2014
Post-transcriptional regulation of ITGB6 protein levels in damaged skeletal muscle
Melissa Ducceschi, Lisa G Clifton, Stephen A Stimpson, et al.
Histochemistry and Cell Biology
|
March 3, 2007
Expression profiling of peroxisome proliferator-activated receptor-delta (PPAR-delta) in mouse tissues using tissue microarray
Hiroyuki Higashiyama, Andrew N Billin, Yuji Okamoto, et al.
Molecular Pharmacology
|
February 10, 2007
A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity
Michael Schupp, Joshua C Curtin, Roy J Kim, et al.
BMC Nephrology
|
May 15, 2025
Plasma proteome signatures of ASK1 inhibition by selonsertib associate with efficacy in the MOSAIC randomized trial for diabetic kidney disease
Vladimir Petrovic, Andrew Whiteman, Matt Peach, et al.
Aging Cell
|
May 4, 2016
Lack of evidence for GDF11 as a rejuvenator of aged skeletal muscle satellite cells
Aaron C Hinken, Janine M Powers, Guizhen Luo, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 55) with videos related to
Sort By:
Page
of 6
Expert Opinion on Investigational Drugs
|
September 24, 2008
PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home
Andrew N Billin
Skeletal Muscle
|
February 2, 2013
Satellite cell therapy - from mice to men
Akshay Bareja, Andrew N Billin
Methods in Molecular Biology (Clifton, N.J.)
|
May 9, 2018
Isolation of Skeletal Muscle Stem Cells for Phenotypic Screens for Modulators of Proliferation
Aaron C Hinken, Andrew N Billin
Current Opinion in Investigational Drugs (London, England : 2000)
|
May 10, 2008
PPARbeta/delta ligands as modulators of the inflammatory response
Kenneth S Kilgore, Andrew N Billin
Biochimica Et Biophysica Acta
|
July 3, 2007
The next generation of PPAR drugs: do we have the tools to find them?
Barry G Shearer, Andrew N Billin
Journal of Molecular Histology
|
February 4, 2014
Post-transcriptional regulation of ITGB6 protein levels in damaged skeletal muscle
Melissa Ducceschi, Lisa G Clifton, Stephen A Stimpson, et al.
Histochemistry and Cell Biology
|
March 3, 2007
Expression profiling of peroxisome proliferator-activated receptor-delta (PPAR-delta) in mouse tissues using tissue microarray
Hiroyuki Higashiyama, Andrew N Billin, Yuji Okamoto, et al.
Molecular Pharmacology
|
February 10, 2007
A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity
Michael Schupp, Joshua C Curtin, Roy J Kim, et al.
BMC Nephrology
|
May 15, 2025
Plasma proteome signatures of ASK1 inhibition by selonsertib associate with efficacy in the MOSAIC randomized trial for diabetic kidney disease
Vladimir Petrovic, Andrew Whiteman, Matt Peach, et al.
Aging Cell
|
May 4, 2016
Lack of evidence for GDF11 as a rejuvenator of aged skeletal muscle satellite cells
Aaron C Hinken, Janine M Powers, Guizhen Luo, et al.
Page
of 6